Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Na ïve Metastatic Uveal Melanoma

Condition:   Melanoma, Uveal Interventions:   Drug: Pembrolizumab;   Drug: Lenvatinib Sponsors:   Providence Health & Services;   Merck Sharp & Dohme Corp.;   Eisai Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials